Hosted on MSN7h
Anavex Sciences Soars On Earnings Relief, EU Filing Acceptance For Alzheimer’s Drug: Retail’s OverjoyedAnavex Life Sciences Corp. shares rocketed over 27% on Monday, hitting their highest levels since February 2023, fueled by a ...
Cytokinetics (NASDAQ:CYTK) said EU regulators have validated the market application for its drug aficamten for the treatment ...
Anavex (AVXL) stock rallied 30% Monday after the company announced EU regulators had accepted the market application for its ...
Life Sciences announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorization Application, ...
Cytokinetics (CYTK) announced that the European Medicines Agency, EMA, has validated the Marketing Authorization Application, MAA, for ...
The Wall Street Journal on MSN7d
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing PermissionIn one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...
The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...
The Polish initiative establishes a proactive strategy for securing access to essential medicines and maintaining ...
11d
Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...
The biopharmaceutical company Friday said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use covers seladelpar in combination with ursodeoxycholic ...
Merck & Co. said a key European regulatory committee has recommended conditional approval of its Welireg oral cancer drug in a pair of indications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback